 Justices today blocked a deal that would have had the Sackler family contribute $6 billion and relinquish ownership of the company. Under the initial agreement, which the court ruled against, Purdue Pharma would have emerged from bankruptcy as a different entity, with its profits used for treatment and prevention. The 5-4 decision weakens the ability of corporations and insiders to use bankruptcy to try to avoid mass litigation.